Utilizing the Beat AML dataset of 560 patients with RNAseq data, published by our group in collaboration with others, we ranked all de-novo samples by normalized AHR expression with “high” and “low” expression groups based on the 90th and 10th percentiles, respectively. This evidence concerns the gene AHR and acute myeloid leukemia.